LearnSkin

This master class will cover a comprehensive review of the scientific and clinical evidence for topical and systemic JAK inhibitors in AD. There are new developments in the understanding of the pathogenesis of atopic dermatitis and in the JAK-STAT pathway, now with both topical and oral options. We will explore these in detail, including when and how to use these new agents.

Sponsored By

Faculty

User: peter.lio@dermveda.com
Peter Lio
MD

Dr. Peter Lio is a Clinical Assistant Professor of Dermatology and Pediatrics at the Northwestern University Feinberg School of Medicine. He received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children's Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and has spoken nationally and internationally about atopic dermatitis, as well as alternative medicine.

View Bio

Related Courses

LearnSkin Logo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2024.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!